Literature DB >> 24055103

A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein.

Elisabeth Aubert-Foucher1, Nathalie Mayer1, Marielle Pasdeloup1, Aurélie Pagnon2, Daniel Hartmann3, Frédéric Mallein-Gerin4.   

Abstract

Type II collagen, the major fibrillar collagen of cartilage, is synthesized as precursor forms (procollagens) containing N- and C-terminal propeptides. Three splice variants are thought to be translated to produce procollagen II isoforms (IIA/D and IIB) which differ in their amino propeptide parts. The IIA and IID are transient embryonic isoforms that include an additional cysteine-rich domain encoded by exon 2. The IIA and IID transcripts are co-expressed during chondrogenesis then decline and the IIB isoform is the only one expressed and synthesized in fully differentiated chondrocytes. Additionally, procollagens IIA/D can be re-expressed by dedifferentiating chondrocytes and in osteoarthritic cartilage. Therefore, it is an important point to determine which isoform(s) is (are) synthesized in vivo in normal and pathological situations and in vitro, to fully assess the phenotype of cells producing type II collagen protein. Antibodies directed against the cysteine-rich extra domain found in procollagens IIA and IID are already available but antibodies detecting only the chondrogenic IIB form of type II procollagen were missing so far. A synthetic peptide encompassing the junction between exon 1 and exon 3 of the human sequence was used as immunogen to produce rabbit polyclonal antibodies to procollagen IIB. After affinity purification on immobilized peptide their absence of crossreaction with procollagens IIA/D and with the fibrillar procollagens I, III and V was demonstrated by Western blotting. These antibodies were used to reveal at the protein level that the treatment of dedifferentiated human chondrocytes by bone morphogenic protein (BMP)-2 induces the synthesis of the IIB (chondrocytic) isoform of procollagen II. In addition, immunohistochemical staining of bovine cartilage demonstrates the potential of these antibodies in the analysis of the differential spatiotemporal distribution of N-propeptides of procollagens IIA/D and IIB during normal development and in pathological situations.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Cartilage; Chondrocytes; New antibodies; Type II procollagen

Mesh:

Substances:

Year:  2013        PMID: 24055103     DOI: 10.1016/j.matbio.2013.09.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  6 in total

1.  Characterization of a murine type IIB procollagen-specific antibody.

Authors:  Debabrata Patra; Elizabeth DeLassus; Audrey McAlinden; Linda J Sandell
Journal:  Matrix Biol       Date:  2013-11-07       Impact factor: 11.583

2.  Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.

Authors:  Romain Contentin; Magali Demoor; Miranda Concari; Mélanie Desancé; Fabrice Audigié; Thomas Branly; Philippe Galéra
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

3.  Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.

Authors:  Mélanie Desancé; Romain Contentin; Lélia Bertoni; Tangni Gomez-Leduc; Thomas Branly; Sandrine Jacquet; Jean-Marc Betsch; Agnès Batho; Florence Legendre; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2018-02-10       Impact factor: 5.923

4.  A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.

Authors:  Yunyun Luo; Yi He; Ditte Reker; Natasja Stæhr Gudmann; Kim Henriksen; Ole Simonsen; Christoph Ladel; Martin Michaelis; Ali Mobasheri; Morten Karsdal; Anne-Christine Bay-Jensen
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

5.  Evaluation Avocado Soybean Unsaponifiables Loaded in Poly (lactic-co-glycolic) Acid/Avocado Soybean Unsaponifiables-Fibrin Nanoparticles Scaffold (New Delivery System) is an Effective Factor for Tissue Engineering.

Authors:  Mona Gorji; Anoosheh Zargar Kharazi; Mohsen Setayeshmehr; Nazem Ghasemi; Mitra Soleimani; Batool Hashemibeni
Journal:  Adv Biomed Res       Date:  2021-12-25

6.  Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.

Authors:  Thomas Branly; Romain Contentin; Mélanie Desancé; Thibaud Jacquel; Lélia Bertoni; Sandrine Jacquet; Frédéric Mallein-Gerin; Jean-Marie Denoix; Fabrice Audigié; Magali Demoor; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2018-02-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.